Increased intrahepatic apoptosis but reduced immune activation in HIV-HBV co-infected patients with advanced immunosuppression

AIDS

Volumn 25, Issue 2, 2011, Pages 197-205

  Iser, David M ^a,b   Avihingsanon, Anchalee ^c   Wisedopas, Naruemon ^c   Thompson, Alexander J ^d   Boyd, Alison ^e   Matthews, Gail V ^f   Locarnini, Stephen A ^d   Slavin, John ^e   Desmond, Paul V ^a   Lewin, Sharon R ^a,g,h  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c CHULALONGKORN UNIVERSITY   (Thailand)

^d VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^e ST VINCENT S HOSPITAL   (Australia)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

^g BURNET INSTITUTE   (Australia)

^h MONASH UNIVERSITY   (Australia)

Author keywords

apoptosis; hepatitis B virus; HIV; immunohistochemistry; liver

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA SMOOTH MUSCLE ACTIN; ANTIRETROVIRUS AGENT; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; TENOFOVIR;

ADULT; APOPTOSIS; ARTICLE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; KUPFFER CELL; LIVER BIOPSY; MALE; MIXED INFECTION; MONOCYTE; NATURAL KILLER CELL; NICK END LABELING; PRIORITY JOURNAL; STELLATE CELL; T LYMPHOCYTE ACTIVATION; VIRUS REPLICATION;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; APOPTOSIS; DNA, VIRAL; FEMALE; HEPATITIS B, CHRONIC; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSION; KILLER CELLS, NATURAL; LIVER; MALE; POLYMERASE CHAIN REACTION; VIRAL LOAD;

EID: 78650923206     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283410ccb     Document Type: Article

References (51)

1. Alter M. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 2006; 44 (1 Suppl):6-9.
2. Bodsworth N, Donovan B, Nightingale B. The effect of concurrent human immunodeficiency virus infection on chronic hepatitis B: a study of 150 homosexual men. J Infect Dis 1989; 160:577-582.
3. Colin JF, Cazals-Hatem D, Loriot MA, Martinot-Peignoux M, Pham BN, Auperin A, et al. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology 1999; 29:1306-1310.
4. Puoti M, Cozzi-Lepri A, Paraninfo G, Arici C, Moller N, Lundg-ren J, et al. Impact of lamivudine on the risk of liver-related death in 2041 HBsAg- and HIV-positive individuals: results from an inter-cohort analysis. Antivir Ther 2006; 11:567-574.
5. Rosenthal E, Salmon-Ceron D, Lewden C, Bouteloup V, Pialoux G, Bonnet F, et al. Liver-related deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 study in collaboration with the Mortalité 2005 survey, ANRS EN19). HIV Med 2009; 10:282-289.
6. Hoffmann C, Seaberg E, Young S, Witt M, D'Acunto K, Phair J, et al. Hepatitis B and long-term HIV outcomes in coinfected HAART recipients. AIDS 2009; 23:1881-1889.
7. Gilson RJ, Hawkins AE, Beecham MR, Ross E, Waite J, Briggs M, et al. Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. AIDS 1997; 11:597-606.
8. Goldin R, Fish D, Hay A, Waters J, McGarvey M, Main J, et al. Histological and immunohistochemical study of hepatitis B virus in human immunodeficiency virus infection. J Clin Pathol 1990; 43:203-205. (Pubitemid 20087569)
9. Knodell R, Ishak K, Black W, Chen T, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1:431-435.
10. Chang JJ, Wightman F, Bartholomeusz A, Ayres A, Kent SJ, Sasadeusz J, et al. Reduced hepatitis B virus (HBV)-specific CD4R T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretro-viral therapy. J Virol 2005; 79:3038-3051.
11. Chang J, Sirivichayakul S, Avihingsanon A, Thompson A, Revill P, Iser D, et al. Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfection. J Virol 2009; 83:7649-7658.
12. Crane M, Sirivichayakul S, Chang J, Avihingsanon A, Ubolyam S, Buranapraditkun S, et al. No increase in hepatitis B virus (HBV)-specific CD8R T cells in patients with HIV-1-HBV coinfections following HBV-active highly active antiretroviral therapy. J Virol 2010; 84:2657-2665.
13. Hellerstein M, Hanley M, Cesar D, Siler S, Papageorgopoulos C, Wieder E, et al. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat Med 1999; 5:83-89.
14. Hazenberg M, Stuart J, Otto S, Borleffs J, Boucher C, de Boer R, et al. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretro-viral therapy (HAART). Blood 2000; 95:249-255.
15. Valdez H, Lederman M. Cytokines and cytokine therapies in HIV infection. AIDS Clin Rev 1997-; 1998:187-228.
16. Brenchley J, Price D, Schacker T, Asher T, Silvestri G, Rao S, et al. Microbial translocation isa causeofsystemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365-1371.
17. Brenchley J, Douek D. HIV infection and the gastrointestinal immune system. Mucosal Immunol 2008; 1:23-30.
18. Mehandru S, Poles M, Tenner-Racz K, Horowitz A, Hurley A, Hogan C, et al. Primary HIV-1 infection is associated with preferential depletion of CD4R T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 2004; 200:761-770.
19. Jiang W, Lederman M, Hunt P, Sieg S, Haley K, Rodriguez B, et al. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J Infect Dis 2009; 199:1177-1185.
20. Hunt P, Martin J, Sinclair E, Bredt B, Hagos E, Lampiris H, et al. T cell activation is associated with lower CD4R T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis 2003; 187:1534-1543.
21. Paik YH, Schwabe RF, Bataller R, Russo MP, Jobin C, Brenner DA. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 2003; 37:1043-1055.
22. Dolganiuc A, Norkina O, Kodys K, Catalano D, Bakis G, Marshall C, et al. Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection. Gastroenterology 2007; 133:1627-1636.
23. Thurman R. Mechanisms of hepatic toxicity II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. Am J Physiol Gastrointest Liver Physiol 1998; 275:G605-G611.
24. Matthews GV, Avihingsanon A, Lewin SR, Amin J, Rerknimitr R, Petcharapirat P, et al. A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naive individuals in Thailand. Hepatology 2008; 48:187-228.
25. Thompson A, Nguyen T, Iser D, Ayres A, Jackson K, Littlejohn M, et al. Serum HBsAg and HBeAg titres: disease phase influences correlation with viral load and intrahepatic HBV markers. Hepatology 2010; 51:1933-1944.
26. Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol 2008; 6:1315-1341.
27. Bowden S, Jackson K, Littlejohn M, Locarnini S. Quantification of HBV covalently closed circular DNA from liver tissue by real-time PCR. Methods Mol Med 2004; 95:41-50.
28. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24:289-293.
29. Lok A. Chronic hepatitis B. N Engl J Med 2002; 346:1682-1683.
30. Chu C, Liaw Y. Natural history of chronic hepatitis B virus infection: an immunopathological study. J Gastroenterol He-patol 1997; 12:S218-222.
31. Kim CW, Yoon SK, Jung ES, Jung CK, Jang JW, Kim MS, et al. Correlation of hepatitis B core antigen and B-catenin expression on hepatocytes in chronic hepatitis B virus infection: relevance to the severity of liver damage and viral replication. J Gastroenterol Hepatol 2007; 22:1534-1542.
32. Lugli A, Tornillo L, Mirlacher M, Bundi M, Sauter G, Terraccia-no L. Hepatocyte paraffin 1 expression in human normal and neoplastic tissues: tissue microarray analysis on 3940 tissue samples. Am J Clin Pathol 2004; 122:721-727.
33. Macias J, Japon M, Saez C, Palacios R, Mira J, Garcia-Garcia J, et al. Increased hepatocyte Fas expression and apoptosis in HIV and hepatitis C virus coinfection. J Infect Dis 2005; 192:1566-1576.
34. Weber A, Boger R, Vick B, Urbanik T, Haybaeck J, Zoller S, et al. Hepatocyte-specific deletion of the antiapoptotic protein mye-loid cell leukemia-1 triggers proliferation and hepatocarcino-genesis in mice. Hepatology 2010; 51:1226-1236.
35. Rapicetta M, Ferrari C, Levrero M. Viral determinants and host immune responses in the pathogenesis of HBV infection. J Med Virol 2002; 67:454-457.
36. Iser D, Lewin S. The pathogenesis of liver disease in the setting of HIV-hepatitis B virus coinfection. Antivir Ther 2009; 14:155-164.
37. Iser D, Warner N, Revill P, Solomon A, Wightman F, Saleh S, et al. Co-infection of hepatic cell lines with HIV-hepatitis B virus (HBV) leads to an increase in intracellular hepatitis B surface antigen (HBsAg). J Virol 2010; 84:5860-5867.
38. Wang H-C, Wu H-C, Chen C-F, Fausto N, Lei H-Y, Su I-J. Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress. Am J Pathol 2003; 163:2441-2449.
39. Warner N, Locarnini S. The antiviral drug selected hepatitis B virus rtA181T/sW172M mutant has a dominant negative secretion defect and alters the typical profile of viral rebound. Hepatology 2008; 48:88-98.
40. Desmet V. Milestones in liver disease. Scoring chronic hepatitis. J Hepatol 2003; 38:382-386.
41. Pernollet M, Jouvin-Marche E, Leroy V, Vigan I, Zarski J, Marche P. Simultaneous evaluation of lymphocyte subpopulations in the liver and in peripheral blood mononuclear cells of HCV-infected patients: relationship with histological lesions. Clin Exp Immunol 2002; 130:518-525.
42. Crispe I, Dao T, Klugewitz K, Mehal W, Metz D. The liver as a site of T-cell apoptosis: graveyard, or killing field? Immunol Rev 2000; 174:47-62.
43. Bertolino P, Bowen D, McCaughan G, Fazekas de St Groth B. Antigen-specific primary activation of CD8R T cells within the liver. J Immunol 2001; 166:5430-5438.
44. Crane M, Oliver B, Matthews G, Avihingsanon A, Ubolyam S, Markovska V, et al. Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapy. J Infect Dis 2009; 199:974-981.
45. Roe B, Coughlan S, Hassan J, Grogan A, Farrell G, Norris S, et al. Elevated serum levels of interferon- gamma -inducible protein-10 in patients coinfected with hepatitis C virus and HIV. J Infect Dis 2007; 196:1053-1057.
46. Shields P, Morland C, Salmon M, Qin S, Hubscher S, Adams D. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J Immunol 1999; 163:6236-6243.
47. Crispe I. The liver as a lymphoid organ. Annu Rev Immunol 2009; 27:147-163.
48. Bruno R, Galastri S, Sacchis P, Cima S, Caligiuri A, DeFranco R, et al. gp120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis. Gut 2010; 59:513-520.
49. Hong F, Tuyama A, Lee T, Loke J, Agarwal R, Cheng X, et al. Hepatic stellate cells express functional CXCR4: role in stromal cell-derived factor-1a-mediated stellate cell activation. Hepa-tology 2009; 49:2055-2067.
50. Tuyama A, Hong F, Saiman Y, Wang C, Ozkok D, Mosoian A, et al. Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: implications for the pathogenesis of HIV/hepatitis C virus-induced liver fibrosis. Hepatology 2010; 52:612-622.
51. Yao G. Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China. Gut 1996; 38 (Suppl 2): 39-42.